Xtant Medical Holdings, Inc. Common Stock (XTNT)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Aug 16, 2026Investment Snapshot
- Trading 4% below Graham Number — thin margin of safety
- Piotroski F-Score 6/9 — moderate financial health
- Loss-making — negative ROE of -19.1%
- Revenue growing at 14% annually
Xtant Medical Holdings, Inc. Common Stock (XTNT) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the AMEX , with a market capitalisation of $43 million . Key value metrics: P/E ratio 23.5, P/B ratio 1.07, Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Xtant Medical Holdings, Inc. Common Stock — Fundamental Analysis Summary
Xtant Medical Holdings, Inc. Common Stock (XTNT) is trading 4% below its Graham Number of $0.32, offering a thin margin of safety. The stock carries an elevated trailing P/E ratio of 23.5x.
On financial health, XTNT shows a moderate Piotroski F-Score of 6/9, and negative return on equity of -19.1% (sector average: -20.1%), and minimal leverage with a debt-to-equity ratio of 0.18.
StockPik's composite Value Score for XTNT is 82/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
XTNT reports a high gross margin of 63.6% (sector average: 37.4%) and a negative operating margin of -4.4%.
XTNT shows revenue growing at 14% year-over-year, with earnings growing at 130%.